These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21958302)

  • 21. Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
    Rashid S; Fields AR; Baumrucker SJ
    Am J Hosp Palliat Care; 2018 Mar; 35(3):511-513. PubMed ID: 28641445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
    Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
    Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous botulinum toxin for chronic post-thoracotomy pain.
    Fabregat G; Asensio-Samper JM; Palmisani S; Villanueva-Pérez VL; De Andrés J
    Pain Pract; 2013 Mar; 13(3):231-4. PubMed ID: 22716282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
    Freund B; Rao A
    Pain Pract; 2019 Jun; 19(5):541-551. PubMed ID: 30742360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin - neuropathic pain: Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence based medicine on the use of botulinum toxin for headache disorders.
    Schulte-Mattler WJ; Leinisch E
    J Neural Transm (Vienna); 2008; 115(4):647-51. PubMed ID: 17994180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin for the treatment of sialorrhea: a meta-analysis.
    Vashishta R; Nguyen SA; White DR; Gillespie MB
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A.
    Chien KH; Lu DW; Chen YH; Cheng JH; Chen JT
    J Glaucoma; 2010; 19(8):546-50. PubMed ID: 20164800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain.
    Singer BJ; Silbert BI; Silbert PL; Singer KP
    Toxins (Basel); 2015 Aug; 7(9):3388-404. PubMed ID: 26308056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Botulinum toxin treatment in children].
    Sätilä H; Vähäsarja V; Paavilainen P
    Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.